Boris Oklander
Fondatore presso C2i Genomics, Inc.
Profilo
Boris Oklander is the founder of C2i Genomics, Inc. which is founded in 2019, where he currently holds the title of Chief Technology Officer.
He also worked as the Chief Algorithm Developer at GBooking Ltd.
Dr. Oklander received his undergraduate, graduate, and doctorate degrees from Technion-Israel Institute of Technology.
Posizioni attive di Boris Oklander
Società | Posizione | Inizio |
---|---|---|
C2i Genomics, Inc.
C2i Genomics, Inc. Packaged SoftwareTechnology Services C2i Genomics, Inc. is engaged in the research and development on cancer. It provides ultrasensitive test for cancer. The company was founded by Asaf Zviran and Ezra Sofer in 2019 and is headquartered in New York, NY. | Fondatore | 01/01/2019 |
Precedenti posizioni note di Boris Oklander
Società | Posizione | Fine |
---|---|---|
GBooking Ltd.
GBooking Ltd. Packaged SoftwareTechnology Services GBooking Ltd. develops and provides online appointment scheduling software solutions. It provides small and medium-sized businesses with web-based online promotion and advertising tools. The company was founded by Alexander Naslednikov, Liran Gavish, Alexander Bryzgalov, Ronen Kagan and Fadi Karkaby in 2010 and is headquartered in Haifa, Israel. | Corporate Officer/Principal | - |
Formazione di Boris Oklander
Technion-Israel Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
GBooking Ltd.
GBooking Ltd. Packaged SoftwareTechnology Services GBooking Ltd. develops and provides online appointment scheduling software solutions. It provides small and medium-sized businesses with web-based online promotion and advertising tools. The company was founded by Alexander Naslednikov, Liran Gavish, Alexander Bryzgalov, Ronen Kagan and Fadi Karkaby in 2010 and is headquartered in Haifa, Israel. | Technology Services |
C2i Genomics, Inc.
C2i Genomics, Inc. Packaged SoftwareTechnology Services C2i Genomics, Inc. is engaged in the research and development on cancer. It provides ultrasensitive test for cancer. The company was founded by Asaf Zviran and Ezra Sofer in 2019 and is headquartered in New York, NY. | Technology Services |
- Borsa valori
- Insiders
- Boris Oklander